Eli Lilly's Zepbound Gets FDA OK for Multi-Dose Pen

Core Viewpoint - The company announced that its weight-loss drug will be available at the same self-pay price in both single-dose vial format and multi-dose pen format, which allows for four weekly injections from a single device [1] Group 1 - The weight-loss drug will be offered in two formats: single-dose vials and multi-dose pens [1] - The multi-dose pen format enables patients to receive four weekly injections from one device [1]